ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CUE Cue Biopharma Inc

2,13
0,25 (13,30%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cue Biopharma Inc CUE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,25 13,30% 2,13 00:10:12
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,90 1,87 2,19 2,13 1,88
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202416:01GLOBECue Biopharma to Present at the 2024 American Society of..
08.4.202422:05GLOBECue Biopharma Reports Fourth Quarter and Full Year 2023..
02.4.202414:00GLOBECue Biopharma to Host Business Update Call and Webcast
08.3.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202416:00GLOBECue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured..
22.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202414:00GLOBECue Biopharma to Present Corporate Update at the..
04.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202314:00GLOBECue Biopharma to Present at the JMP Securities Hematology..
09.11.202322:05GLOBECue Biopharma Reports Third Quarter 2023 Financial Results..
07.11.202314:00GLOBECue Biopharma to Present at Three Upcoming Investor..
03.11.202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202317:00GLOBECue Biopharma Presents New Positive Data from Phase 1 Trials..
02.11.202313:00GLOBECue Biopharma to Host Business Update Call and Webcast
27.9.202315:05GLOBECue Biopharma Announces Upcoming Scientific Presentations at..
26.9.202314:00GLOBECue Biopharma Announces Completion of Patient Enrollment in..
14.9.202322:01EDGAR2Form 8-K - Current report
29.8.202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:10GLOBECue Biopharma Reports Second Quarter 2023 Financial Results..
08.8.202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202314:00GLOBECue Biopharma to Host Business Update Call and Webcast
25.7.202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.7.202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.6.202314:00GLOBECue Biopharma to Present at the Federation of Clinical..
07.6.202314:00GLOBECue Biopharma to Host Investor Call
05.6.202314:00GLOBECue Biopharma to Present at the Jefferies 2023 Global..
25.5.202323:00GLOBECue Biopharma Presents Positive Data Update from Ongoing..
15.5.202314:00GLOBECue Biopharma to Present at the 2023 American Society of..
09.5.202322:35GLOBECue Biopharma Reports First Quarter 2023 Financial Results..
08.5.202314:00GLOBECue Biopharma to Present at the Upcoming JMP Securities Life..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock